首站-论文投稿智能助手
典型文献
Absolute bioavailability,dose proportionality,and tissue distribution of rotundic acid in rats based on validated LC-QqQ-MS/MS method
文献摘要:
Rotundic acid(RA),an ursane-type pentacyclic triterpene acid isolated from the dried barks of Ilex rotunda Thunb.(Aquifoliaceae),possesses diverse bioactivities.To further study its pharmacokinetics,a simple and sensitive liquid chromatography with triple quadrupole mass spectrometry(LC-QqQ-MS/MS)method was developed and validated to quantify RA concentration in rat plasma and tissue using etofesalamide as an internal standard(IS).Plasma and tissue samples were subjected to one-step protein precipitation.Chromatographic separation was achieved on a ZORBAX Eclipse XDB-C18 col-umn(4.6 mm×50 mm,5 μm)under gradient conditions with eluents of methanol:acetonitrile(1∶1,V/V)and 5mM ammonium formate:methanol(9∶1,V/V)at 0.5mL/min.Multiple reaction monitoring transitions were performed at m/z 487.30 → 437.30 for RA and m/z 256.10 → 227.10 for IS in the negative mode.The developed LC-QqQ-MS/MS method exhibited good linearity(2-500 ng/mL)and was fully validated in accordance with U.S.Food and Drug Administration bioanalytical guidelines.Dose proportionality and bioavailability in rats were determined by comparing pharmacokinetic data after single oral(10,20,and 40 mg/kg)and intravenous(10 mg/kg)administration of RA.Tissue distribution was studied following oral administration at 20 mg/kg.The results showed that the absolute bioavailability of RA after administration at different doses ranged from 16.1%to 19.4%.RA showed good dose proportionality over a dose range of 10-40 mg/kg.RA was rapidly absorbed in a dose-dependent manner and highly distributed in the liver.In conclusion,this study is the first to systematically elucidate the absorption and distribution characteristics of RA in rats,which can provide additional information for further development and evaluation of RA in drug metabolism and pharmacokinetic studies.
文献关键词:
作者姓名:
Haihua Shang;Xiaohan Dai;Mi Li;Yueyi Kai;Zerong Liu;Min Wang;Quansheng Li;Yuan Gu;Changxiao Liu;Duanyun Si
作者机构:
School of Pharmacy,Shenyang Pharmaceutical University,Shenyang,110016,China;State Key Laboratory of Drug Delivery and Pharmacokinetics,Tianjin Institute of Pharmaceutical Research,Tianjin,300301,China;Research Unit for Drug Metabolism,Chinese Academy of Medical Sciences,Tianjin,300301,China
引用格式:
[1]Haihua Shang;Xiaohan Dai;Mi Li;Yueyi Kai;Zerong Liu;Min Wang;Quansheng Li;Yuan Gu;Changxiao Liu;Duanyun Si-.Absolute bioavailability,dose proportionality,and tissue distribution of rotundic acid in rats based on validated LC-QqQ-MS/MS method)[J].药物分析学报(英文),2022(02):278-286
A类:
rotundic,Rotundic,ursane,pentacyclic,etofesalamide,eluents
B类:
Absolute,bioavailability,proportionality,tissue,distribution,acid,rats,validated,LC,QqQ,method,RA,type,triterpene,isolated,from,dried,barks,Ilex,rotunda,Thunb,Aquifoliaceae,possesses,diverse,bioactivities,To,further,study,its,pharmacokinetics,simple,sensitive,liquid,chromatography,triple,quadrupole,mass,spectrometry,was,developed,quantify,concentration,plasma,using,internal,standard,IS,Plasma,samples,were,subjected,one,step,protein,precipitation,Chromatographic,separation,achieved,ZORBAX,Eclipse,XDB,C18,col,umn,under,gradient,conditions,methanol,acetonitrile,5mM,ammonium,formate,5mL,Multiple,reaction,monitoring,transitions,performed,negative,mode,exhibited,good,linearity,fully,accordance,Food,Drug,Administration,bioanalytical,guidelines,Dose,determined,by,comparing,data,after,single,oral,intravenous,administration,Tissue,studied,following,results,showed,that,absolute,different,doses,ranged,over,rapidly,absorbed,dependent,manner,highly,distributed,liver,In,conclusion,this,first,systematically,elucidate,absorption,characteristics,which,can,provide,additional,information,development,evaluation,drug,metabolism,studies
AB值:
0.582244
相似文献
The complexation of insulin with sodium N-[8-(2-hydroxybenzoyl)amino]-caprylate for enhanced oral delivery:Effects of concentration,ratio,and pH
Huixian Weng;Lefei Hu;Lei Hu;Yihan Zhou;Aohua Wang;Ning Wang;Wenzhe Li;Chunliu Zhu;Shiyan Guo;Miaorong Yu;Yong Gan-School of Chinese Materia Medica,Nanjing University of Chinese Medicine,Nanjing 210046,China;State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;School of Pharmacy,Nanjing University of Chinese Medicine,Nanjing 210023,China;Nano Science and Technology Institute,University of Science and Technology of China,Nanjing 215123,China;University of Chinese Academy of Sciences,Beijing 100049,China;NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients,National Institutes for Food and Drug Control,Beijing 100050,China
Pharmacodynamic,pharmacokinetic,and phase 1a study of bisthianostat,a novel histone deacetylase inhibitor,for the treatment of relapsed or refractory multiple myeloma
Yu-bo Zhou;Yang-ming Zhang;Hong-hui Huang;Li-jing Shen;Xiao-feng Han;Xiao-bei Hu;Song-da Yu;An-hui Gao;Li Sheng;Ming-bo Su;Xiao-li Wei;Yue Zhang;Yi-fan Zhang;Zhi-wei Gao;Xiao-yan Chen;Fa-jun Nan;Jia Li;Jian Hou-National Center for New Drug Screening,State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Yantai Key Laboratory of Nanomedicine&Advanced Preparations,Yantai Institute of Materia Medica,Yantai 264000,China;Department of Hematology,Renji Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 200127,China;Shanghai Center for Drug Metabolism and Pharmacokinetics Research,Shanghai 201203,China
Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway
Yi-kuan Wu;Zheng-nan Ren;Sheng-long Zhu;Yun-zhou Wu;Gang Wang;Hao Zhang;Wei Chen;Zhao He;Xian-long Ye;Qi-xiao Zhai-State Key Laboratory of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Medicine,Jiangnan University,Wuxi 214122,China;College of Life Science,Northeast Agricultural University,Harbin 150038,China;National Engineering Research Center for Functional Food,Jiangnan University,Wuxi 214122,China;Shandong Key Laboratory of Endocrinology and Lipid Metabolism,Jinan 250021,China;School of Medicine,Shandong University,Jinan 250012,China;Ganjiang Chinese Medicine Innovation Center,Nanchang 330000,China
Safety,tolerability,and pharmacokinetics of VV116,an oral nucleoside analog against SARS-CoV-2,in Chinese healthy subjects
Hong-jie Qian;Yu Wang;Meng-qi Zhang;Yuan-chao Xie;Qing-qing Wu;Li-yu Liang;Ye Cao;Hua-qing Duan;Guang-hui Tian;Juan Ma;Zhuo-bing Zhang;Ning Li;Jing-ying Jia;Jing Zhang;Haji Akber Aisa;Jing-shan Shen;Chen Yu;Hua-liang Jiang;Wen-hong Zhang;Zhen Wang;Gang-yi Liu-Central Laboratory,Shanghai Xuhui Central Hospital/Xuhui Hospital,Fudan University,Shanghai 200031,China;Shanghai Engineering Research Center of Phase I Clinical Research and Quality Consistency Evaluation for Drugs,Shanghai 200031,China;CAS Key Laboratory of Receptor Research,Drug Discovery and Design Center,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Lingang Laboratory,Shanghai 201602,China;Clinical Department,Vigonvita Life Sciences Co.,Ltd,Suzhou 215123,China;Research and Development Department,Shanghai Junshi Biosciences Co.,Ltd,Shanghai 200126,China;Phase 1 Clinical Research Center,Huashan Hospital,Fudan University,Shanghai 200040,China;State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization,Xinjiang Technical Institute of Physics and Chemistry,Chinese Academy of Sciences,Urumqi 830011,China;State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Department of Infectious Diseases,Huashan Hospital,Fudan University,Shanghai 200040,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。